Charles Schwab Investment Management Inc Electro Core, Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.27 - $0.61 $12,292 - $27,772	45,528 New	45,528 $24,000
Q2 2021 Aug 16, 2021	SELL	$1.19 - $2.06 $24,841 - $43,002	-20,875 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.62 - $3.05 $33,817 - $63,668	20,875 New	20,875 $44,000
Q2 2020 Aug 14, 2020	SELL	$0.75 - $1.29 $18,671 - $32,114	-24,895 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.84 - $9.07 $65,170 - $122,127	13,465 Added 117.8%	24,895 $175,000
Q3 2018 Nov 13, 2018	BUY	$13.02 - $17.54 $148,818 - $200,482	11,430 New	11,430 $161,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $705M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.